Welcome to our dedicated page for EVACU news (Ticker: EVACU), a resource for investors and traders seeking the latest updates and insights on EVACU stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect EVACU's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of EVACU's position in the market.
EQV Ventures Acquisition Corp. II (NYSE:EVACU) has successfully completed its upsized initial public offering, raising $460 million in gross proceeds. The company sold 42 million units at $10.00 per unit, increased from the initial 35 million units, plus an additional 4 million units through the partial exercise of the over-allotment option.
Each unit comprises one Class A ordinary share and one-third of one redeemable warrant. Whole warrants allow holders to purchase one Class A ordinary share at $11.50 per share. The securities began trading on the NYSE on July 2, 2025, with the Class A shares and warrants expected to trade separately under symbols EVAC and EVACW. BTIG, LLC served as the sole book-running manager for this SPAC offering.
EQV Ventures Acquisition Corp. II (NYSE:EVACU) has announced the pricing of its upsized initial public offering (IPO) of 42 million units at $10.00 per unit, increased from the initially planned 35 million units. The total offering size amounts to $420 million.
Each unit comprises one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant allows holders to purchase one Class A ordinary share at $11.50 per share. The units will trade on the NYSE under "EVACU," while the Class A shares and warrants will later trade separately under "EVAC" and "EVACW" respectively.
BTIG, LLC serves as the sole book-running manager and has been granted a 45-day option to purchase up to 6.3 million additional units to cover over-allotments. The offering is expected to close on July 3, 2025. The SPAC is sponsored by an affiliate of the EQV Group and aims to enter into a business combination with one or more businesses.
